Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 3 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients.
Blood Adv. 2023 Sep 26;7(18):5603-5607. doi: 10.1182/bloodadvances.2023010712.
Blood Adv. 2023.
PMID: 37721859
Free PMC article.
No abstract available.
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.
Kottke T, Tonne J, Evgin L, Driscoll CB, van Vloten J, Jennings VA, Huff AL, Zell B, Thompson JM, Wongthida P, Pulido J, Schuelke MR, Samson A, Selby P, Ilett E, McNiven M, Roberts LR, Borad MJ, Pandha H, Harrington K, Melcher A, Vile RG.
Kottke T, et al. Among authors: schuelke mr.
Nat Commun. 2021 Mar 26;12(1):1930. doi: 10.1038/s41467-021-22115-1.
Nat Commun. 2021.
PMID: 33772027
Free PMC article.
Item in Clipboard
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.
Driscoll CB, Schuelke MR, Kottke T, Thompson JM, Wongthida P, Tonne JM, Huff AL, Miller A, Shim KG, Molan A, Wetmore C, Selby P, Samson A, Harrington K, Pandha H, Melcher A, Pulido JS, Harris R, Evgin L, Vile RG.
Driscoll CB, et al. Among authors: schuelke mr.
Nat Commun. 2020 Feb 7;11(1):790. doi: 10.1038/s41467-020-14568-7.
Nat Commun. 2020.
PMID: 32034147
Free PMC article.
Item in Clipboard
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.
Wongthida P, Schuelke MR, Driscoll CB, Kottke T, Thompson JM, Tonne J, Stone C, Huff AL, Wetmore C, Davies JA, Parker AL, Evgin L, Vile RG.
Wongthida P, et al. Among authors: schuelke mr.
Neuro Oncol. 2020 Dec 18;22(12):1757-1770. doi: 10.1093/neuonc/noaa126.
Neuro Oncol. 2020.
PMID: 32459315
Free PMC article.
Item in Clipboard
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators.
Ayasoufi K, Pfaller CK, Evgin L, Khadka RH, Tritz ZP, Goddery EN, Fain CE, Yokanovich LT, Himes BT, Jin F, Zheng J, Schuelke MR, Hansen MJ, Tung W, Parney IF, Pease LR, Vile RG, Johnson AJ.
Ayasoufi K, et al. Among authors: schuelke mr.
Brain. 2020 Dec 1;143(12):3629-3652. doi: 10.1093/brain/awaa343.
Brain. 2020.
PMID: 33253355
Free PMC article.
Item in Clipboard
Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors.
Schuelke MR, Gundelach JH, Coffey M, West E, Scott K, Johnson DR, Samson A, Melcher A, Vile RG, Bram RJ.
Schuelke MR, et al.
Neurooncol Adv. 2022 Jun 17;4(1):vdac085. doi: 10.1093/noajnl/vdac085. eCollection 2022 Jan-Dec.
Neurooncol Adv. 2022.
PMID: 35821679
Free PMC article.
Item in Clipboard
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity.
Schuelke MR, Wongthida P, Thompson J, Kottke T, Driscoll CB, Huff AL, Shim KG, Coffey M, Pulido J, Evgin L, Vile RG.
Schuelke MR, et al.
J Immunother Cancer. 2019 Jul 17;7(1):188. doi: 10.1186/s40425-019-0673-2.
J Immunother Cancer. 2019.
PMID: 31315671
Free PMC article.
Item in Clipboard
Cite
Cite